Delivery Order SPE2DR25D3016-SPE2DR26FG1VM
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,517.14 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed price contract, awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award utilized no set-aside...
- The Defense Logistics Agency awarded a $1,526.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180ml), a medication used to treat attention deficit hyperactivity disorder. The award, issued on November 26, 2025, with completion targeted for November 28, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The contract involves no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $3,274.31 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (60 ml), a pharmaceutical product used in treating attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 4, 2025, for Quillivant XR 25 mg/5 mL suspension in a 120 mL quantity, valued at $2,035.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and represents a pediatric attention-deficit/hyperactivity disorder (ADHD) medication delivery to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,827.25 on October 23, 2025, with an ultimate completion date of October 24, 2025. The order is for Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, a brand-name ADHD medication. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,494.96 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (150 ml), a pharmaceutical product used in attention-deficit/hyperactivity disorder treatment. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $2,962.82, represents a non-competitive set-aside award and is scheduled for completion by September 23, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,347.48 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of Quillivant 25mg/5ml (methylphenidate extended-release suspension), a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The place of...
- The Defense Logistics Agency (DLA) awarded a $1,896.96 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,308.96 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This competitively awarded, firm fixed price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...